Although the biostatistical scientific literature publishes new methods at a very high rate, many of these developments are not trustworthy enough to be adopted by the scientific community. We propose a framework to think about how a piece of methodological work contributes to the evidence base for a method. Similarly to the well-known phases of clinical research in drug development, we define four phases of methodological research. These four phases cover (I) providing logical reasoning and proofs, (II) providing empirical evidence, first in a narrow target setting, then (III) in an extended range of settings and for various outcomes, accompanied by appropriate application examples, and (IV) investigations that establish a method as sufficiently well-understood to know when it is preferred over others and when it is not. We provide basic definitions of the four phases but acknowledge that more work is needed to facilitate unambiguous classification of studies into phases. Methodological developments that have undergone all four proposed phases are still rare, but we give two examples with references. Our concept rebalances the emphasis to studies in phase III and IV, i.e., carefully planned methods comparison studies and studies that explore the empirical properties of existing methods in a wider range of problems.
翻译:虽然生物统计学科学文献以极高的速度公布了新方法,但许多这些发展不够可靠,无法为科学界所采用。我们提议了一个框架,以思考某一项方法工作如何有助于一种方法的证据基础。与众所周知的药物发展的临床研究阶段一样,我们界定了方法研究的四个阶段。这四个阶段包括(一) 提供逻辑推理和证明,(二) 提供经验证据,首先在狭窄的目标设定中,然后(三) 在广泛的环境和各种结果中提供经验证据,并辅以适当的应用实例;以及(四) 进行调查,确定一种方法,在足够深地理解的情况下,确定一种方法,在选择其他方法时,在不选择这种方法时,确定一种方法。我们提供了四个阶段的基本定义,但承认需要做更多的工作,以便利将研究明确分为各个阶段。经过所有四个拟议阶段的方法学发展仍然很少,但我们举两个例子。我们的概念重新平衡了第三阶段和第四阶段研究的重点,即仔细规划的方法比较和研究,以探讨现有方法在更广泛的问题中的经验特性。